Apyx Medical Income Statement (2010-2026) | APYX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Income Statement	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Revenue & cost
Revenue (Quarter)	11.22M	11.83M	16.82M	12.49M	10.29M	9.11M	12.61M	12.14M	13.57M	11.98M	14.66M	10.24M	12.15M	11.49M	14.22M	9.43M	11.37M	12.88M	19.16M	12.49M
Cost of Revenue (Quarter)	3.69M	3.77M	4.67M	4.27M	3.38M	3.36M	4.37M	4.57M	4.29M	4.00M	5.73M	4.29M	4.66M	4.53M	5.26M	3.77M	4.29M	4.58M	7.17M	4.57M
Gross Profit (Quarter)	7.53M	8.06M	12.15M	8.22M	6.91M	5.76M	8.24M	7.57M	9.28M	7.98M	8.93M	5.95M	7.49M	6.95M	8.96M	5.67M	7.08M	8.30M	12.00M	7.92M
Operating items
Research & Development (Quarter)	1.08M	1.18M	0.95M	1.16M	1.07M	1.06M	1.25M	1.27M	1.36M	1.41M	1.40M	1.40M	1.42M	1.14M	1.12M	0.80M	0.82M	0.80M	0.97M	0.77M
Selling, General & Administrative (Quarter)	4.26M	4.61M	6.02M	5.46M	4.54M	4.67M	5.81M	5.25M	5.38M	4.84M	6.72M	4.90M	4.84M	4.29M	4.83M	3.38M	4.14M	3.66M	4.62M	3.58M
Other Operating Expenses (Quarter)	0.10M	-0.19M	-0.18M	-0.02M	0.61M	-0.04M	-0.55M	-0.01M	2.69M			-0.02M	-0.00M	0.02M	-0.16M	4.53M	4.69M	0.08M	0.02M	0.04M
Operating Expenses (Quarter)	11.58M	12.02M	13.84M	14.09M	12.89M	11.54M	14.17M	13.18M	13.21M	12.62M	14.70M	12.56M	13.04M	10.59M	12.01M	8.72M	9.66M	9.13M	11.99M	8.84M
Operating Income (Quarter)	-4.04M	-3.97M	-1.69M	-5.87M	-5.98M	-5.78M	-5.93M	-5.61M	-1.24M	-4.64M	-5.78M	-6.62M	-5.55M	-3.63M	-3.05M	-3.05M	-2.57M	-0.83M	0.01M	-0.91M
EBIT (Quarter)	-4.04M	-3.97M	-1.69M	-5.87M	-5.98M	-5.78M	-5.93M	-5.61M	-1.24M	-4.64M	-5.78M	-6.62M	-5.55M	-3.63M	-3.05M	-3.05M	-2.57M	-0.83M	0.01M	-0.91M
Non-operating items
Interest & Investment Income (Quarter)										0.25M	0.44M	0.49M	0.44M	0.38M	0.29M	0.30M	0.28M	0.29M	0.23M	0.24M
Other Non Operating Income (Quarter)	0.10M	-0.19M	-0.18M	-0.03M	0.62M	0.04M	-0.63M	-0.19M	0.28M	-0.02M	-3.71M	-0.02M	-0.00M	0.02M	-0.16M
Non Operating Income (Quarter)	0.10M	-0.19M	-0.18M	-0.03M	0.62M	0.04M	0.02M	-0.19M	0.28M	-0.36M	-4.64M	-0.02M	-0.00M	-1.03M	-1.52M	-1.07M	-1.11M	-1.04M	-1.16M	-1.09M
Net income details
EBT (Quarter)	-3.94M	-4.16M	-1.88M	-5.90M	-5.35M	-5.75M	-5.91M	-5.80M	-0.95M	-4.99M	-9.54M	-7.54M	-6.54M	-4.66M	-7.03M	-4.12M	-3.69M	-1.88M	-1.15M	-2.00M
Tax Provisions (Quarter)	0.11M	0.07M	0.13M	0.07M	0.10M	0.05M	0.15M	-2.27M	0.07M	-0.32M	0.09M	0.05M	0.05M	0.06M	0.09M	0.05M	0.05M	0.08M	0.09M	0.14M
Profit After Tax (Quarter)	-4.05M	-4.22M	-2.03M	-5.95M	-5.45M	-5.76M	-6.05M	-3.53M	-1.02M	-4.63M	-9.61M	-7.59M	-6.59M	-4.70M	-4.56M	-4.17M	-3.74M	-1.96M	-1.35M	-2.11M
Income from Non-Controlling Interests (Quarter)	-0.01M	-0.01M	-0.01M	-0.02M	-0.02M	-0.03M	-0.02M	-0.05M	-0.03M	-0.05M	-0.02M	-0.01M	-0.03M	-0.02M	-0.03M	-0.02M	0.04M	0.03M	0.06M	-0.04M
Income from Continuing Operations (Quarter)	-4.05M	-4.23M	-2.01M	-5.97M	-5.45M	-5.79M	-6.07M	-3.53M	-1.02M	-4.67M	-9.62M	-7.59M	-6.59M	-4.72M	-7.11M	-4.17M	-3.74M	-1.96M	-1.24M	-2.14M
Consolidated Net Income (Quarter)	-4.05M	-4.23M	-2.01M	-5.97M	-5.45M	-5.79M	-6.07M	-3.53M	-1.02M	-4.67M	-9.62M	-7.59M	-6.59M	-4.72M	-7.11M	-4.17M	-3.74M	-1.96M	-1.24M	-2.14M
Income towards Parent Company (Quarter)	-4.05M	-4.23M	-2.01M	-5.97M	-5.45M	-5.79M	-6.07M	-3.53M	-1.02M	-4.67M	-9.62M	-7.59M	-6.59M	-4.72M	-7.11M	-4.17M	-3.74M	-1.96M	-1.24M	-2.14M
Net Income towards Common Stockholders (Quarter)	-4.05M	-4.23M	-2.01M	-5.97M	-5.45M	-5.79M	-6.07M	-3.53M	-1.02M	-4.63M	-9.61M	-7.58M	-6.56M	-4.70M	-4.63M	-4.15M	-3.78M	-1.98M	-1.30M	-2.11M
Additional items
EPS (Basic) (Quarter)	-0.12	-0.12	-0.06	-0.17	-0.16	-0.17	-0.17	-0.10	-0.03	-0.13	-0.28	-0.22	-0.19	-0.14	-0.12	-0.10	-0.09	-0.05	-0.03	-0.05
EPS (Weighted Average and Diluted) (Quarter)	-0.12	-0.12	-0.06	-0.17	-0.16	-0.17	-0.17	-0.10	-0.03	-0.13	-0.28	-0.22	-0.19
Shares Outstanding (Weighted Average) (Quarter)	34.31M	34.32M	34.33M	34.43M	34.46M	34.49M	34.52M	34.60M	34.60M	34.64M	34.62M	34.64M	34.64M	34.64M	35.54M	40.73M	40.73M	40.73M	41.09M	43.74M
Shares Outstanding (Diluted Average) (Quarter)			34.33M				34.52M				34.62M
EBITDA (Quarter)	-4.04M	-3.97M	-1.69M	-5.87M	-5.98M	-5.78M	-5.93M	-5.61M	-1.24M	-4.64M	-5.78M	-6.62M	-5.55M	-3.63M	-3.05M	-3.05M	-2.57M	-0.83M	0.01M	-0.91M
Interest Expenses (Quarter)	0.00M	0.00M	0.00M	0.01M	0.00M	0.00M	0.00M	0.23M	0.54M	0.58M	1.12M	1.40M	1.43M	1.43M	1.65M	1.38M	1.39M	1.41M	1.41M	1.37M
Tax Rate (Quarter)	-2.71%	-1.75%	-7.14%	-1.19%	-1.79%	-0.87%	-2.55%	39.09%	-6.93%	6.37%	-0.91%	-0.70%	-0.76%	-1.29%	-1.27%	-1.19%	-1.33%	-4.16%	-8.20%	-7.15%

Research Tools

Apyx Medical Income Statement (2010-2026) | APYX

Create an account

Sign In

Reset Password